Sanctuary Advisors LLC Buys 887 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Sanctuary Advisors LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,496 shares of the medical device company’s stock after buying an additional 887 shares during the period. Sanctuary Advisors LLC’s holdings in Cooper Companies were worth $4,071,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Victory Capital Management Inc. raised its holdings in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $691,000. Highland Capital Management LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $4,004,000. Franklin Resources Inc. grew its position in shares of Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after purchasing an additional 32,260 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Cooper Companies by 6.6% in the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after purchasing an additional 14,687 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.2 %

COO stock opened at $88.48 on Friday. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a market cap of $17.66 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 2.19 and a beta of 1.00. The business’s 50-day simple moving average is $92.94 and its 200 day simple moving average is $99.55. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.87 earnings per share. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the topic of several research analyst reports. Citigroup lowered their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Morgan Stanley lowered their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.